glp gip glucagon & cagrilintide Effects of GLP-1 (blue arrows), (red arrows) and (green Identification and utility exploration of

Hypothesis 3 Glycemic control beyond retatrutide alone Cagrilintide adds postprandial glucagon suppression a mechanism retatrutide does not engage

The theoretical 3-8% additional weight loss from adding cagrilintide to tirzepatide doesn't justify the significantly amplified side effects, 2-3x higher cost ($1,200-2,400 monthly), lack of physician support for experimental protocols, and unknown long-term safety profile

The in vitro hippocampal-neuron-culture spine-density work used Dihexa concentrations across a wide range, with effects observed at picomolar concentrations [2]

Bioorg Med

The Sikiric groups foundational research, published in major pharmacology journals and indexed at the NIH National Library of Medicine, demonstrates direct gastroprotective and anti-inflammatory action in the gut mucosa